Arriving in the landscape of weight management therapy, retatrutide is a unique method. Different from many existing medications, retatrutide operates as a twin agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. The dual activation fosters several helpful effects, such